1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. CVRX INC

CVRx Inc XNAS: CVRX

CVRx Inc Live Share Price Today, Share Analysis and Chart

Weak Stock
Download real time

6.25 0.10 (1.63%)

66.31% Fall from 52W High

241.6K XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for CVRx Inc is on 30 Apr 2025 for the purpose of CVRx Inc First Quarter Earnings Results for 2025 See details

CVRx Inc Key Metrics

Select

Market Capitalization

Below industry Median
162.7

PE TTM

Negative PE TTM
-2.7

PEG TTM

Below industry Median
0.1

Price to Book

Below industry Median
2.3

Institutional holding current Qtr %

Below industry Median
58.3

Revenue Growth Qtr YoY %

High in industry
35.7

Operating Revenue growth TTM %

High in industry
30.5

Net Profit Qtr Growth YoY %

Negative Net Profit Qtr Growth YoY %
-16.2

Net Profit TTM Growth %

Negative Net Profit TTM Growth %
-45.5

Operating Profit Margin Qtr %

Negative Operating Profit Margin Qtr %
-67

Operating Profit Margin TTM %

Negative Operating Profit Margin TTM %
-116

Piotroski Score

Below industry Median
2

Rel Perf vs Sector quarter%

-57.3

ROE Annual %

Negative ROE Annual %
-81.6

RoA Annual %

Negative RoA Annual %
-48.2
All financials are in USD Million and price data in USD
VIEW MORE
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
15.0 / 100
Momentum Score
Technically Bearish
28.7 / 100
Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
17
1Yr Price target upside is 169%
6 analysts

9

S

19

W

4

O

2

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


CVRx Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '260255075100Actual RevenueAvg. Estimate
Hit

CVRx Inc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

Current EPS
-2.6
Avg. Estimate
-2
Low Estimate
-2.3
High Estimate
-1.5
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 22.6% in FY25

Consensus Recommendation

7 ANALYST Recommendations
STRONG BUY

Created with Highcharts 7.2.21Hold1Buy5Strong Buy

The consensus recommendation from 7 analysts for CVRx Inc is STRONG BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

CVRx Inc Stock Analysis

CVRx Inc stock analysis with key metrics, changes, and trends.

CVRx Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$51.29 M30.53%positive

Annual Revenue rose 30.53%, in the last year to $51.29 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit$59.96 M45.55%negative

Annual Net Profit fell 45.55% in the last year to $59.96 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio-2.71-negative

Price to Earning Ratio is -2.71, which is negative.

Stock Price$6.25-59.04%negative

Stock Price fell 59.04% and underperformed its sector by 64.47% in the past year.

Quarterly Revenue$15.34 M35.71%positive

Quarterly Revenue rose 35.71% YoY to $15.34 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit$10.65 M16.24%negative

Quarterly Net profit fell 16.24% YoY to $10.65 M. Its sector's average net profit growth YoY for the quarter was 32.89%.

Debt to Equity Ratio0.71-positive

Debt to Equity Ratio of 0.71 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)-81.58 %-81.58%negative

Return on Equity(ROE) for the last financial year was -81.58%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding18.91 %1.03%positive

Mutual Fund Holding increased by 1.03% in the last quarter to 18.91.

Interest Coverage Ratio-12.63-negative

Interest Coverage Ratio is -12.63, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding58.35 %0.03%positive

Institutional Holding increased by 0.03% in the last quarter to 58.35.

VIEW LESS


Loading data..

CVRx Inc - Company Profile

What does CVRx Inc do?

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

CVRx Inc Management structure

All Gross Remunerations are in USD
Mr. Kevin Hykes, M.B.A.
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year
Mr. Nadim Yared
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year
Mr. Jared Oasheim
Chief Financial Officer and Principal Accounting Officer
-
2024
Gross Remuneration
Year

CVRx Inc Board of directors

All Gross Remunerations are in USD
Mr. Kevin Hykes, M.B.A.
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year
Mr. Nadim Yared
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year
Mr. Kevin J. Ballinger
Independent Director
-
2024
Gross Remuneration
Year
Dr. Ali Behbahani, M.B.A.,M.D.
Independent Director
-
2024
Gross Remuneration
Year
Mr. Mitchell C. Hill
Independent Director
-
2024
Gross Remuneration
Year
Mr. Joseph P. Slattery, C.P.A.
Independent Director
-
2024
Gross Remuneration
Year

CVRx Inc FAQ

How is CVRx Inc today?
CVRx Inc today is trading in the green, and is up by 1.63% at 6.25.
CVRx Inc is currently trading up 1.63% on an intraday basis. In the past week the stock rose 0.32%. stock has been down -64.53% in the past quarter and fell -59.04% in the past year. You can view this in the overview section.